LIDDS AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 - Marketscreener.com
| LIDDS Stock | SEK 0.11 0.01 8.33% |
Slightly above 62% of Lidds AB's investor base is looking to short. The analysis of current outlook of investing in Lidds AB suggests that many traders are alarmed regarding Lidds AB's prospects. Lidds AB's investing sentiment can be driven by a variety of factors including economic data, Lidds AB's earnings reports, geopolitical events, and overall market trends.
Lidds AB stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Lidds daily returns and investor perception about the current price of Lidds AB as well as its diversification or hedging effects on your existing portfolios.
Lidds |
LIDDS AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 Marketscreener.com
Read at news.google.com
 |
Lidds AB Fundamental Analysis
We analyze Lidds AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lidds AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lidds AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Liabilities
Current Liabilities Comparative Analysis
Lidds AB is currently under evaluation in current liabilities category among its peers. Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Lidds AB Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Lidds AB stock to make a market-neutral strategy. Peer analysis of Lidds AB could also be used in its relative valuation, which is a method of valuing Lidds AB by comparing valuation metrics with similar companies.
Peers
Lidds AB Related Equities
| GOMX | GomSpace Group | 2.70 | ||||
| ZEAL | Zealand Pharma | 0.62 | ||||
| BINV | BioInvent International | 1.57 | ||||
| HNSA | Hansa Biopharma | 1.59 | ||||
| ORPHA | Orphazyme | 10.12 |
Additional Tools for Lidds Stock Analysis
When running Lidds AB's price analysis, check to measure Lidds AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lidds AB is operating at the current time. Most of Lidds AB's value examination focuses on studying past and present price action to predict the probability of Lidds AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lidds AB's price. Additionally, you may evaluate how the addition of Lidds AB to your portfolios can decrease your overall portfolio volatility.